China Shineway Pharmaceutical Group Limited

CSWYY · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income$85$30$478
Dep. & Amort.$10$10$91
Deferred Tax$0$0$0
Stock-Based Comp.$0$0$0
Change in WC$0$0-$168
Other Non-Cash$0$22$210
Operating Cash Flow$95$62$611
Investing Activities
PP&E Inv.-$14-$9-$95
Net Acquisitions$2$1$0
Inv. Purchases-$187-$14$0
Inv. Sales/Matur.$235-$34$0
Other Inv. Act.$4$1$99
Investing Cash Flow$39-$56$4
Financing Activities
Debt Repay.-$0$0$0
Stock Issued$0$0$0
Stock Repurch.$0$0$0
Dividends Paid-$37-$12-$83
Other Fin. Act.-$1-$1-$6
Financing Cash Flow-$38-$12-$89
Forex Effect$20-$11-$1
Net Chg. in Cash$116-$17-$5,365
Supplemental Information
Beg. Cash$841$858$5,365
End Cash$957$841$5,365
Free Cash Flow$81$53$516